- Home
- TECH vs CTRE Comparison
TECH vs CTRE Comparison
Compare TECH & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CTRE
- Stock Information
- Founded
- TECH 1976
- CTRE 2013
- Country
- TECH United States
- CTRE United States
- Employees
- TECH N/A
- CTRE N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CTRE Real Estate Investment Trusts
- Sector
- TECH Health Care
- CTRE Real Estate
- Exchange
- TECH Nasdaq
- CTRE Nasdaq
- Market Cap
- TECH 8.3B
- CTRE 7.5B
- IPO Year
- TECH 1989
- CTRE N/A
- Fundamental
- Price
- TECH $52.88
- CTRE $34.49
- Analyst Decision
- TECH Buy
- CTRE Buy
- Analyst Count
- TECH 12
- CTRE 6
- Target Price
- TECH $70.91
- CTRE $33.00
- AVG Volume (30 Days)
- TECH 2.1M
- CTRE 1.8M
- Earning Date
- TECH 10-29-2025
- CTRE 10-28-2025
- Dividend Yield
- TECH 0.62%
- CTRE 3.89%
- EPS Growth
- TECH N/A
- CTRE 108.23
- EPS
- TECH 0.46
- CTRE 1.21
- Revenue
- TECH $1,219,635,000.00
- CTRE $373,415,000.00
- Revenue This Year
- TECH $4.13
- CTRE $17.85
- Revenue Next Year
- TECH $7.56
- CTRE $28.06
- P/E Ratio
- TECH $112.02
- CTRE $28.49
- Revenue Growth
- TECH 5.23
- CTRE 50.83
- 52 Week Low
- TECH $46.01
- CTRE $24.79
- 52 Week High
- TECH $80.95
- CTRE $34.92
- Technical
- Relative Strength Index (RSI)
- TECH 49.85
- CTRE 61.11
- Support Level
- TECH $50.96
- CTRE $34.03
- Resistance Level
- TECH $53.75
- CTRE $34.63
- Average True Range (ATR)
- TECH 1.74
- CTRE 0.55
- MACD
- TECH -0.20
- CTRE -0.09
- Stochastic Oscillator
- TECH 55.01
- CTRE 85.27
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.